-
Oct 13, 2024 | 
digitimes.com | Ian Chan |Jingyue Hsiao |DIGITIMES Asia
Similar to Abenomics' three arrows over a decade ago, Japan is now introducing three initiatives aimed at reversing the decline in its semiconductor industry. Professor Kuroda Tadayoshi from the University of Tokyo has compared this effort to "a frog...
-
Sep 29, 2024 | 
digitimes.com | Ian Chan |Levi Li |DIGITIMES Asia
In early September, SEMICON Taiwan 2024 was held in Taipei. This annual global semiconductor event gathered leading semiconductor companies and industry elites from around the world to explore the latest semiconductor technologies and future industry...
-
Sep 19, 2024 | 
kevinmd.com | Oluyemisi Famuyiwa |Ian Chan |Philip A. Masters |Arthur Lazarus
Epigenetics has revolutionized our understanding of how lifestyle factors—such as diet, stress, exercise, and environmental exposures—affect fertility. Unlike genetic mutations, which change the DNA sequence, epigenetic changes modify how genes are expressed without altering the DNA itself. These changes occur through mechanisms such as DNA methylation and histone modifications, and they play a critical role in fertility.
-
Jun 5, 2024 | 
mondaq.com | Ian Chan
In the intricate landscape of divorce proceedings, it is
often said that the welfare of the child remains the preeminent,
unwavering consideration to be safeguarded above all
else.
This is particularly true when it comes to the well-being of
children with special education needs (SENs). Amongst the most SENs
are conditions such as autism spectrum disorder (ASD),
attention-deficit/hyperactivity disorder (ADHD), and dyslexia.
-
May 12, 2024 | 
kevinmd.com | Marc Arginteanu |Ian Chan |Molly Walker |Shetal Shah
A bunch of symptoms, which may persist many months or even years after an acute COVID infection has cleared, have been described in the medical literature with increasing frequency since the onset of the pandemic. This constellation of findings has been dubbed “long COVID.” Long COVID’s effects on the brain, in particular, have certainly been in the news, and it’s also been popping up in the medical literature.
-
Dec 30, 2023 | 
healthcarebusinesstoday.com | Ian Chan |Eugene Chan
After years of upward trajectory, 2023 marked a year of fluctuation for biopharmaceutical companies. The industry has battled supply chain issues and inflation, while simultaneously still securing new. While not a simple year for anyone, one area of this industry that has encountered the most hurdles has been the oncology sector of the biopharmaceutical industry.
-
Nov 15, 2023 | 
medcitynews.com | Ian Chan
No two cancer diagnoses are the same, creating an even greater complexity for an already mystifying disease. Although there have been decades of extensive research, treatment plans and insurance coverage rely on the same forms of therapy that date back to the 1940’s: chemotherapy and radiation. After diagnosis, physicians and care team members work together to develop a unique treatment plan that fits the needs of the patient.
-
Oct 12, 2023 | 
kevinmd.com | Ryan McCarthy |Ian Chan |Edwin Leap |Tatum R. Dam |Ryan McCarthy
I am perplexed by two different needles which, when viewed together, illustrate the irrational themes which dominate our shared humanity. They inform me that, despite being a doctor for more than twenty years, I honestly feel dumber each day about human behavior. If, unlike me, you have somehow figured out more along the way, good for you. The first needle which vexes me was the one stuck in my arm on Saturday, December 19, 2020.
-
Sep 19, 2023 | 
digitimes.com | Ian Chan
Silicon photonics technology was hotly discussed during the SEMICON Taiwan 2023. At the Silicon Photonics Global Summit held September 5 alongside the exhibition, I was invited to join discussions with experts from TSMC, ASE, Industrial Technology Research...
-
Aug 30, 2023 | 
bioprocessonline.com | Ian Chan
By Ian Chan, Abpro
Over the last two years, the shortage of cancer drugs has become a national crisis, putting patients at risk of worsened conditions or, in some cases, even death. There are two drugs in particular that are causing doctors to pause, as these are often unavailable — cisplatin and carboplatin — which are both essential for basic cancer treatment and care.
